![Martin E. Sanders](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin E. Sanders
Oprichter bij
Seurat Therapeutics, Inc.
Profiel
Martin E.
Sanders is the founder of Seurat Therapeutics, Inc., Io Therapeutics, Inc. Former positions include President & Chief Executive Officer at Palingen, Inc. (US) from 2004 to 2008 and Chief Development Officer & EVP at Dynavax Technologies Corp.
in 2008.
Education includes an undergraduate degree from the University of Missouri and a doctorate from The University of Chicago.
Actieve functies van Martin E. Sanders
| Bedrijven | Functie | Begin |
|---|---|---|
Seurat Therapeutics, Inc.
 Seurat Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates pre-clinical biotechnology company that develops nasal sprays to alleviate and prevent future migraines | Oprichter | - |
Io Therapeutics, Inc.
 Io Therapeutics, Inc. BiotechnologyHealth Technology Develops retinoid and rexinoid molecule drugs for treatment of cancer | Algemeen Directeur | 01-01-2011 |
Eerdere bekende functies van Martin E. Sanders
| Bedrijven | Functie | Einde |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 01-11-2008 |
Palingen, Inc. (US) | President | 01-01-2008 |
Opleiding van Martin E. Sanders
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
6
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Io Therapeutics, Inc.
Io Therapeutics, Inc. BiotechnologyHealth Technology Develops retinoid and rexinoid molecule drugs for treatment of cancer | Health Technology |
University of Missouri
 University of Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Palingen, Inc. (US) | |
Seurat Therapeutics, Inc.
Seurat Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates pre-clinical biotechnology company that develops nasal sprays to alleviate and prevent future migraines | Commercial Services |
